157 related articles for article (PubMed ID: 10369478)
21. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain.
Raurich A; Mengod G; Artigas F; Cortés R
Synapse; 1999 Oct; 34(1):68-76. PubMed ID: 10459173
[TBL] [Abstract][Full Text] [Related]
22. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
Millan MJ; Newman-Tancredi A; Lochon S; Touzard M; Aubry S; Audinot V
Pharmacol Biochem Behav; 2002 Apr; 71(4):589-98. PubMed ID: 11888550
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
[TBL] [Abstract][Full Text] [Related]
24. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
25. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
Mongeau R; De Montigny C; Blier P
Eur J Pharmacol; 1994 May; 256(3):269-79. PubMed ID: 8045271
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding.
Giles H; Lansdell SJ; Bolofo ML; Wilson HL; Martin GR
Br J Pharmacol; 1996 Mar; 117(6):1119-26. PubMed ID: 8882605
[TBL] [Abstract][Full Text] [Related]
27. Coupling of an endogenous 5-HT1B-like receptor to increases in intracellular calcium through a pertussis toxin-sensitive mechanism in CHO-K1 cells.
Dickenson JM; Hill SJ
Br J Pharmacol; 1995 Dec; 116(7):2889-96. PubMed ID: 8680721
[TBL] [Abstract][Full Text] [Related]
28. Affinity of (+/-)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain.
Castro ME; Harrison PJ; Pazos A; Sharp T
J Neurochem; 2000 Aug; 75(2):755-62. PubMed ID: 10899952
[TBL] [Abstract][Full Text] [Related]
29. 5,7-Dihydroxytryptamine lesions enhance and serotonergic grafts normalize the evoked overflow of acetylcholine in rat hippocampal slices.
Birthelmer A; Schweizer T; Jeltsch H; Jackisch R; Cassel JC
Eur J Neurosci; 2002 Nov; 16(10):1839-49. PubMed ID: 12453047
[TBL] [Abstract][Full Text] [Related]
30. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites.
Engel G; Göthert M; Hoyer D; Schlicker E; Hillenbrand K
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):1-7. PubMed ID: 2936965
[TBL] [Abstract][Full Text] [Related]
31. Detection and characterization of the serotonin 5-HT 1D receptor in rat and human brain.
Herrick-Davis K; Titeler M
J Neurochem; 1988 May; 50(5):1624-31. PubMed ID: 3361315
[TBL] [Abstract][Full Text] [Related]
32. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
Scott C; Soffin EM; Hill M; Atkinson PJ; Langmead CJ; Wren PB; Faedo S; Gordon LJ; Price GW; Bromidge S; Johnson CN; Hagan JJ; Watson J
Eur J Pharmacol; 2006 Apr; 536(1-2):54-61. PubMed ID: 16571351
[TBL] [Abstract][Full Text] [Related]
33. Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout.
Ase AR; Reader TA; Hen R; Riad M; Descarries L
J Neurochem; 2001 Aug; 78(3):619-30. PubMed ID: 11483665
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.
Dreshfield LJ; Wong DT; Perry KW; Engleman EA
Neurochem Res; 1996 May; 21(5):557-62. PubMed ID: 8726963
[TBL] [Abstract][Full Text] [Related]
35. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.
Blurton PA; Wood MD
J Neurochem; 1986 May; 46(5):1392-8. PubMed ID: 3958711
[TBL] [Abstract][Full Text] [Related]
36. Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors.
De Vivo M; Maayani S
Biochem Pharmacol; 1990 Oct; 40(7):1551-8. PubMed ID: 2222510
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):1-12. PubMed ID: 3002805
[TBL] [Abstract][Full Text] [Related]
38. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
Zemlan FP; Schwab EF
J Neurochem; 1991 Dec; 57(6):2092-9. PubMed ID: 1834802
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
